Special Issue "Biology of Boron Neutron Capture Therapy (BNCT) 2021"

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: 30 September 2021.

Special Issue Editors

Prof. Dr. Wolfgang Sauerwein
E-Mail Website1 Website2
Guest Editor
1. Professor (retired), Radiation Oncology University Duisburg Essen, Germany, University Hospital Essen, Strahlenklinik, Hufelandstr 55, 45122 Essen, Germany
2. Specially Appointed Professor at the Neutron Therapy Research Center, Okayama University, Japan
3. President of the German Society for Boron Neutron Capture Therapy
Interests: radiation oncology; hadron therapy; Boron Neutron Capture therapy (BNCT); neutrons; High LET radiation; radiation biology; eye tumors; ophthalmic oncology
Special Issues and Collections in MDPI journals
Dr. Mitsuko Masutani
E-Mail Website1 Website2
Guest Editor
1. Professor, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan
2. Specially Appointed Chief, Lab of Collaborative Research, Division of Cellular Signaling, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
Interests: radiation oncology; biology in anti-cancer treatment
Special Issues and Collections in MDPI journals
Prof. John Hopewell
E-Mail Website
Guest Editor
Professor and Director (retired), Consultant Radiobiologist of Radiobiological Research at the University of Oxfords, OX1 2JD Oxford, UK
Interests: clinically oriented radiation biology
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

The appearance of hospital-based epithermal neutron sources has made boron neutron capture therapy (BNCT) a dedicated focus of innovative developments in radiation oncology. All future clinical applications have to be based on carefully performed pre-clinical investigations. At this very moment, it seems appropriate and important to collect results of recent preclinical and early clinical research and publish them together with intelligible and clear reviews of the most challenging aspects of BNCT.

This Special Issue of Cells is for contributions on all cytobiological aspects related to BNCT. You are invited to submit your contributions in the form of original research articles, reviews, or shorter perspective articles.

Relevant observations made at the cellular level could come from the following areas:

Radiation biology for BNCT;
Cell-based studies;
Preclinical animal studies;
Drug development for BNCT;
Impact of BNCT on the proteomic profile and omics approaches;
Boron imaging;
Mechanisms of action of BNCT;
Abscopal effect of BNCT;
Early clinical trials;
Biomarkers for therapeutic optimization.

Prof. Wolfgang Sauerwein
Prof. Mitsuko Masutani
Prof. John Hopewell
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Development of imaging for BNCT

Author: Nobuyoshi Fukumitsu

Development of biological laboratories optimized for accelerator-based BNCT facilities and biological characterization tests
Authors: Yoshitaka Matsumoto, Yu Sugawara, Nobuyoshi Fukumitsu, Hiroaki Kumada, and Hideyuki Sakurai

Development of a novel boron-lipid to modify liposomal surface for cancer treatment by boron neutron cancer therapy

Authors: Makoto Shirakawa, Kei Nakai , Yuhki Sato, Tomonori Sakai, Riko Terada, Alexander Zaboronok, Takao Tsurubuchi, Fumiyo Yoshida, Minoru Suzuki, Hiroaki Kumada, Takeji Sakae, Hisao Tomida and Akira Matsumura



Back to TopTop